Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy.

Ng KW., Boumelha J., Enfield KSS., Almagro J., Cha H., Pich O., Karasaki T., Moore DA., Salgado R., Sivakumar M., Young G., Molina-Arcas M., de Carné Trécesson S., Anastasiou P., Fendler A., Au L., Shepherd STC., Martínez-Ruiz C., Puttick C., Black JRM., Watkins TBK., Kim H., Shim S., Faulkner N., Attig J., Veeriah S., Magno N., Ward S., Frankell AM., Al Bakir M., Lim EL., Hill MS., Wilson GA., Cook DE., Birkbak NJ., Behrens A., Yousaf N., Popat S., Hackshaw A., TRACERx Consortium ., CAPTURE Consortium ., Hiley CT., Litchfield K., McGranahan N., Jamal-Hanjani M., Larkin J., Lee S-H., Turajlic S., Swanton C., Downward J., Kassiotis G.